Infectious adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis based on FAERS database
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but their association with infectious adverse events (iAEs) remains incompletely characterized. These infections may arise from immune dysregulation or immunosuppressiv…